The Veterinary Medicines Directorate (VMD) today outlines its comprehensive approach to veterinary medicine safety monitoring following concerns about changes to adverse event reporting processes, confirming interim measures to ensure continued robust pharmacovigilance.

Maintaining Comprehensive Reporting Options

Whilst developing an enhanced online reporting portal, the VMD has ensured there are sufficient reporting routes in place so that no adverse events go unreported. Veterinary professionals can contact the VMD pharmacovigilance team directly where Marketing Authorisation Holder ( MAH ) identification proves challenging or if reports concern an unauthorised or human medicine.

We understand stakeholder concerns about reporting accessibility and are committed to maintaining multip

See Full Page